Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2026-07-27 19:28:40 ET · period of report 2026-07-23 · accession 0001193125-26-318442 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 19:28 | 2026-07-23 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $0.895 | -202.5K | 2.56M | -7% | -$181.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-23 | F | D | 202,476 | $0.895 | 2,563,054 | D | — | — | (F1) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on August 1, 2025, which grant was originally reported on a Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2025. (F2) Includes 5,000 shares of common stock acquired by the reporting person on May 29, 2026 under the Issuer's Employee Stock Purchase Plan. |